---
figid: PMC8745410__jcm-11-00160-g001
figtitle: Development and Use of Akt Inhibitors in Prostate Cancer
organisms:
- Homo sapiens
pmcid: PMC8745410
filename: jcm-11-00160-g001.jpg
figlink: /pmc/articles/PMC8745410/figure/jcm-11-00160-f001/
number: F1
caption: Overview of the PI3K-Akt-mTOR pathway.
papertitle: Overview of the Development and Use of Akt Inhibitors in Prostate Cancer.
reftext: Anis Gasmi, et al. J Clin Med. 2022 Jan;11(1):160.
year: '2022'
doi: 10.3390/jcm11010160
journal_title: Journal of Clinical Medicine
journal_nlm_ta: J Clin Med
publisher_name: MDPI
keywords: prostate cancer | Akt | PTEN | castration resistance | Ipatasertib | Capivasertib
automl_pathway: 0.9363124
figid_alias: PMC8745410__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8745410__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8745410__jcm-11-00160-g001.html
  '@type': Dataset
  description: Overview of the PI3K-Akt-mTOR pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TSC2
  - TSC1
  - CCL26
  - MTOR
  - PTEN
  - PAK1IP1
  - ACD
  - AKT1
  - AKT2
  - AKT3
  - PDK1
  - PDPK1
  - CRTC2
---
